Are you sure?

GVH supports drug market liberalization

The new regulation on the retail sales of OTC drugs currently before Parliament almost fully matches what Competition Office (GVH) earlier suggested, i.e. liberalizing the market, said service sector head Teréz Amberger at a press conference yesterday. The implementation of the new regulation will be advantageous for the patients in several respect, she explained. The sharper competition will make OTC (over-the counter) medicines cheaper and, also, pharmacies cannot but offer several extra services, e.g. delivery, orders via internet. However, GVH finds the regulation of the price margin too expensive for the government. Besides, the condition that a trained pharmacist needs to own a stake in each pharmacies is discriminative because those inheriting a business will not be able to keep it. (Magyar Hírlap)